Money Talks

Test Utilization: Payment Policies More Effective than Practice Recommendations in Curbing Orders of Low-Value Tests

When it comes to getting physicians not to order low-value laboratory tests, money talks. At least, that is the punchline of a new study finding that changes in payment policies are more effective … [Read more...]

LDTs

Laboratory Developed Tests: The VALID Act is Back

With all the attention commanded by the coronavirus crisis, a potentially huge development affecting the future of the lab industry has flown under the radar. What’s at stake is the issue that has … [Read more...]

Emerging Tests: Lab Industry Mobilizes to Develop Coronavirus Detection Test

The global coronavirus (COVID-19) outbreak came without warning and is having a seismic impact on laboratories and the diagnostics business. The imperative for the industry right now is to develop a … [Read more...]

EMERGING TESTS

Targeted Genetic Risk-Based Prostate Cancer Screening Would Save the Most Lives at the Best Costs: UK Study

Targeted screening of men at high genetic risk of the disease could prevent nearly one in six prostate cancer deaths. That is the tantalizing finding of a new computer modeling study led by the … [Read more...]

FDA WATCH

FDA Watch: Agency Resounds the Alarm on Biotin Test Interference

In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The … [Read more...]

TESTING TRENDS

Testing Trends: The Debate Continues Over Regular Colorectal Screening for Average Risk Adults

Should adults age 50 to 75 who are at average risk and show no symptoms of colorectal cancer have regular colorectal screening exams? Last month, a major medical journal came out against regular … [Read more...]

EMERGING TESTS

Nonculture Molecular Tests Speed Diagnosis of Bloodstream Infections

The T2Bacteria Panel (T2Biosystems; Lexington, Mass.) can rapidly and accurately diagnoses bloodstream infections (BSIs) caused by five common bacteria, according to a study published May 14 in the … [Read more...]

PUBLIC HEALTH

CDC Announces Shortage of TB Skin Test Antigen, New TB Testing Guidelines

The U.S. Centers for Disease Control and Prevention (CDC) announced a three-to 10-month national shortage of Aplisol (Par Pharmaceuticals; Chestnut Ridge, N.Y.), one of two purified-protein derivative … [Read more...]

TESTING STRATEGY

Upfront Next-Generation Sequencing for Lung Cancer Patients Saves Time, Money

Use of upfront next-generation sequencing (NGS) testing at diagnosis of patients with metastatic non-small-cell lung cancer (mNSCLC) is associated with substantial cost savings, according to a study … [Read more...]

TESTING TRENDS

Genetic Testing Guidelines for Hereditary Cancer Miss Many At Risk

The National Comprehensive Cancer Network genetic testing criteria for hereditary cancer miss almost one in five at-risk for breast and ovarian cancer, and more than one in three at-risk for Lynch … [Read more...]


(-00000g2)